This PulteGroup, Inc. (NYSE:PHM) data suggests you may want to take a look at the stock. In the 21st century investor’s toolkit, there are tons of gauges investors can use to track stocks. Two of the most underrated are hedge fund and …
Shares of PulteGroup, Inc. closed the previous trading session at 23.71 down -0.06 -0.25% with 4,503,325 shares trading hands. The post Insider Trading Activity PulteGroup, Inc. (NYSE:PHM) – Insider Sold 10,000 shares of Stock
A large portion of that drop happened very quickly in early February when the stock fell from a swing high of $63.43 to the $51.22 low. Since the low the price has rallied back. Since May, the stock is ranging between $63.23 and $56.21, just …
The stock PHM, +1.14% climbed 2% in active afternoon trade, and has now run up 4.1% since it closed Friday at the lowest level since October 2013. Volume as of 2:30 p.m. Eastern was 8.5 million shares, more than 50% above the full …
*Close price adjusted for splits.**Adjusted close price adjusted for both dividends and splits. Loading more data...
If you want a Stock Review on PHM, TMHC, TOL, or TPH then come over to http://dailystocktracker.com/register/ and …
Special to the Times-Union, Pulte Homes (NYSE: PHM) announced today that its Board of Directors has declared a two-for-one stock split to be effected in the form of a 100 percent stock dividend. The additional shares of common stock
Shares of Pulte Homes (NYSE:PHM) opened today above their pivot of $22.21 and have ... price of $0.00 and an average consensus analyst price target of $23.64. The stock should find initial resistance at its 50-day moving average (MA) of …
Is PHM overvalued at current levels? Not sure how awe-some*sto-ck*s finds all these incredible trade ideas but im happy. Is this going to be a bearish head and shoulders stock formation that is beginning to form? If this breaks resistance at …
PharmaMar (PHM) will present the clinical data obtained from various clinical studies carried out with its antitumoral compounds of marine origin PM1183 and Yondelis®, during the European Society of Clinical Oncology (ESMO) that …